What is KRMD's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.14B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for KRMD?

P/E (TTM) is n/a and 52-week range is $2.86 to $6.61 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s KRMD figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for KRMD?

The company profile lists revenue (TTM) near $42M, net income (TTM) near $-169M, EPS (TTM) near $-0.04 when available from the market-data feed. Figures are informational and may lag live markets.

Where is KORU Medical Systems Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Mahwah, New Jersey, US, 45.9M shares outstanding, ISIN US7599101026 when available from company profile and filing metadata.

KORU Medical Systems Inc

$KRMD

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$2.96

-1.33%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 73 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

Employees

Website

www.korumedical.com/

IPO

1993-10-27

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)